Palisade Bio, Inc.

Historical 13F Holders

Symbol
PALI
CUSIP
696389402
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 696389402 since 12/18/2024, largest first.

Filer % of Class Filed
Janus Henderson Group PLC 13G
10.0% 12/8/2025
Event 11/28/2025
RA Capital Management, L.P. 13G/A
9.9% 5/15/2026
Event 3/31/2026
Perceptive Advisors LLC 13G/A
7.9% 5/15/2026
Event 3/31/2026
Soleus Capital Master Fund, L.P. 13G/A
7.5% 8/13/2026
Event 6/30/2026
Octagon Capital Advisors LP 13G
6.4% 2/10/2026
Event 12/31/2025
BlackRock, Inc. 13G 6.0% 7/29/2026
Event 6/30/2026
Franklin Resources, Inc. 13G
6.0% 1/29/2026
Event 12/31/2025
Ameriprise Financial, Inc. 13G
5.3% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Armistice Capital, LLC 13G/A
Amended under CUSIP 44974L301 on 8/14/2025
10.0% 5/15/2025
Event 3/31/2025
Squadron Capital Management LLC 13G/A
3.0% 2/17/2026
Event 12/31/2025
Point72 Asset Management, L.P. 13G/A
0.2% 5/15/2026
Event 3/31/2026
Commodore Capital LP 13G/A
0% 8/14/2026
Event 6/30/2026
Deep Track Capital, LP 13G/A
0% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 4.74 k $6.41 k
2026 Q2 125 173 M $364 M
2026 Q1 96 149 M $262 M
2025 Q4 87 136 M $319 M
2025 Q3 12 120 k $103 k
2025 Q2 12 84.6 k $57.5 k
2025 Q1 14 296 k $201 k
2024 Q4 11 235 k $388 k
2024 Q3 11 106 k $377 k
2024 Q2 10 66.0 k $298 k